Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S0140-6736(20)32137-1 http://scihub22266oqcxt.onion/10.1016/S0140-6736(20)32137-1 33065034!7553736!33065034     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet 2020 ; 396 (10262): 1595-1606 Nephropedia Template TP {{tp|p=33065034|t=2020. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates |pdf=|usr=}}{{33065034}} gab.com Text SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates JO: Lancet http://www.kidney.de/pget.php?&tw=1&pmid=33065034 #FOAvip Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing vaccines, antivirals, and monoclonal antibodies. A mere 11 months ago, the canvas we call COVID-19 was blank. Scientists around the world have worked collaboratively to fill in this blank canvas. In this Review, we discuss what is currently known about human humoral and cellular immune responses to severe acute respiratory syndrome coronavirus 2 and relate this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials. Twit Text FOAVip SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates ????Lancet http://www.kidney.de/pget.php?&tw=1&pmid=33065034 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33065034 #FOAvip English Wikipedia <ref>{{Cite pmid|33065034}}</ref> SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates #MMPMID33065034 Poland GA; Ovsyannikova IG; Kennedy RB Lancet 2020[Nov]; 396 (10262): 1595-1606 PMID33065034show ga Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing vaccines, antivirals, and monoclonal antibodies. A mere 11 months ago, the canvas we call COVID-19 was blank. Scientists around the world have worked collaboratively to fill in this blank canvas. In this Review, we discuss what is currently known about human humoral and cellular immune responses to severe acute respiratory syndrome coronavirus 2 and relate this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials. |*Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Clinical Trials, Phase III as Topic[MESH] |Coronavirus Infections/immunology/*prevention & control[MESH] |Humans[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/immunology/*prevention & control[MESH] |SARS-CoV-2[MESH]SARS-CoV-2 immunity: review and applications to phase 3 vaccine candid(epmc).pdf DeepDyve Pubget Overpricing